Targeting PDGFR-β in Cholangiocarcinoma

Liver International - United Kingdom
doi 10.1111/j.1478-3231.2011.02687.x
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Altered Expression of Β-Catenin Without Genetic Mutation in Intrahepatic Cholangiocarcinoma

Modern Pathology
Forensic MedicinePathology
2001English

MiR-30a-5p Promotes Cholangiocarcinoma Cell Proliferation Through Targeting SOCS3

Journal of Cancer
Oncology
2020English

miR-34a Regulates Mesangial Cell Proliferation via the PDGFR-β/Ras-MAPK Signaling Pathway

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2014English

Targeting Transforming Growth Factor-Β Signaling

Current Opinion in Oncology
Cancer ResearchOncology
2007English

Targeting Β-Cell Functions in Therapy for Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

P3.16-050 Stromal PDGFR-β Expression Influences Postoperative Survival of NSCLC Patients Receiving Preoperative Chemo- Or Chemo-Radiotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Necroptosis in Cholangiocarcinoma

Cells
2020English

Direct Targeting of SUZ12/ROCK2 by miR-200b/c Inhibits Cholangiocarcinoma Tumourigenesis and Metastasis

British Journal of Cancer
Cancer ResearchOncology
2013English

Small Molecule DnaK Modulators Targeting the Β-Domain

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy